Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4 Motor Activity 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Pharyngeal Neoplasms 2 Obesity 2 Laryngeal Neoplasms 2 Diabetes Mellitus, Type 2 2 Colonic Neoplasms 2 Weight Loss 1 Sarcopenia 1 Lung Neoplasms 1 Lung Diseases 1 Liver Neoplasms 1 Liver Diseases 1 Gastrointestinal Neoplasms 1 Chronic Disease 1 COVID-19 1 Brain Neoplasms 1 Body Weight Changes 1

Interventions

Sorafenib 42 Bevacizumab 16 Oxaliplatin 13 Radiosurgery 10 Gemcitabine 10 Doxorubicin 10 Capecitabine 10 Leucovorin 9 Hepatectomy 9 Fluorouracil 9 Cisplatin 9 Radiofrequency Ablation 8 Nivolumab 8 pembrolizumab 7 Drug Therapy 7 Carboplatin 7 Irinotecan 6 Cryosurgery 6 Talaporfin 5 Mitomycin 5 Everolimus 5 Erlotinib Hydrochloride 5 Electroporation 5 spartalizumab 4 Sunitinib 4 Melphalan 4 Ipilimumab 4 Epirubicin 4 Embolization, Therapeutic 4 regorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × Nutritional Status × Clear all

NCT05281211 2025-04-18

NEXPREM

San Camillo Hospital, Rome

Phase NA Completed

Gastrointestinal

Liver Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡